B.DornG
Upon completion, participants will be able to: Explain the mechanisms of action, therapeutic effects, and limitations of GLP-1 RAs Develop individualized treatment plans that integrate GLP-1 RA therapy with lifestyle interventions to support sustainable weight loss and improve management of related comorbidities Apply best practices in medication titration, side effect management, and patient counseling to support safe and sustainable care Click here to enroll for free
Situations where CJC-1295 would generally be considered inappropriate or high-risk include: Active or prior cancer , given the theoretical role of elevated IGF-1 in tumor growth Diabetes or impaired glucose tolerance , because GH can worsen insulin resistance and raise blood sugar Pregnancy and breastfeeding , where there are no safety data whatsoever Children and adolescents , in whom manipulating the GH axis outside strict medical indications is inappropriate Serious cardiovascular, kidney, or liver disease , which fluid retention and metabolic shifts could aggravate Interactions to consider
Results may vary depending on individual metabolism, baseline nutrient levels, and overall health
